好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

2004 Annual Meeting | Cerebrovascular Disease: Prevention

Wednesday 04/28/04
02:15 PM - 03:45 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Cerebrovascular Disease and Interventional Neurology
No CME available
Event Timeline
02:15 PM - 03:45 PM Abstract 001 - In-Hospital Initiation of Secondary Prevention for Symptomatic Cerebrovascular Atherosclerosis Yields High Rates of Compliance at Follow-Up
02:15 PM - 03:45 PM Abstract 002 - Triflusal for Prevention of Cerebral Ischemic Infarction: Results of the TAPIRSS Trial
02:15 PM - 03:45 PM Abstract 003 - Does the Underuse of Appropriate Medication as a Function of Patient and Physician Behavior Influence Early Stroke Recurrence Rates?
02:15 PM - 03:45 PM Abstract 004 - Stroke Subtyping in the 21[sup]st[/sup] Century: The STOPStroke Study[rsquo]s (SSS) Modified-TOAST Classification Scheme
02:15 PM - 03:45 PM Abstract 005 - Asymptomatic Carotid Surgery Trial (ACST): Interim Five Year Results
02:15 PM - 03:45 PM Abstract 006 - Physician Preferences for Diagnosis and Treatment of Symptomatic Intracranial (IC) Arterial Stenosis
Faculty Disclosures
Larry B. Goldstein, MD, FAHA, FAAN The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from NIH. The institution of Dr. Goldstein has received research support from Janssen. Dr. Goldstein has received publishing royalties from a publication relating to health care.
Jeffrey L. Saver, MD, FAAN Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.
Angelo Antonini, MD Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BIAL. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Antonini has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for THERAVANCE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ABBVIE. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for ZAMBON. Dr. Antonini has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BOEHRINGER.
Kallol R. Chaudhuri, MD, FRCP Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Abbvie, Acadia, GSK, Scion, Britannia , Lobsor. Dr. Chaudhuri has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie, Britannia, Scion, Sunovion, UCB, . Dr. Chaudhuri has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie, Britannia, UCB, Zambon. Dr. Chaudhuri has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NPJ PD journal. The institution of Dr. Chaudhuri has received research support from Britania Pharmaceuticals, AbbVie, UCB, GKC, Bial, Aacdemic grants: EU, IMI EU, Horizon 2020, Parkinson's UK, NIHR, PDNMG, EU (Horizon 2020), Kirby Laing Foundation, NPF, MRC, Wellcome Trust.
Jorge D. Correale, MD Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .
Werner Poewe, MD Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Affiris . Werner Poewe, MD has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity, AbbVie, BIAL, Biogen, Britannia, Lilly, Lundbeck, Neuroderm, Neurocrine, Denali Pharmaceuticals, ,Roche, Takeda, UCB and Zambon . Werner Poewe, MD has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie, Britannia, BIAL, STADA, Lundbeck, Zambon. The institution of Werner Poewe, MD has received research support from MJFF; EU Horizon programme. Werner Poewe, MD has a non-compensated relationship as a Committee member with Movement Disorder Society that is relevant to AAN interests or activities.
Demetrius M. Maraganore, MD, FAAN The institution of Dr. Maraganore has received research support from Agency for Healthcare Research and Quality. The institution of Dr. Maraganore has received research support from Florida Department of Health.
No disclosure on file
Stephanie P. Dubow, DO No disclosure on file
Sajish Jacob, MBBS No disclosure on file
Hirohisa Watanabe, MD, PhD Dr. Watanabe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Takeda. Dr. Watanabe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Watanabe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Watanabe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ono . Dr. Watanabe has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Avvie.
Shabbir Hussain I. Merchant, MD No disclosure on file
Nicole D. Reams, MD, FAAN Dr. Reams has stock in Beyond Barriers Therapeutics.
Qaisar A. Shah, MD No disclosure on file
Mauricio F. Farez, MD Dr. Farez has nothing to disclose.
Ashley Yegin No disclosure on file
Varun Naragum, MD No disclosure on file
Takashi Tsuboi, PhD No disclosure on file
Nancy E. Bass, MD Dr. Bass has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elseviert.
Archana Hinduja, MD Dr. Hinduja has nothing to disclose.
Alok Sachdeva, MD No disclosure on file
Roberta Frigerio, MD Dr. Frigerio has nothing to disclose.
Ricky Lee, MD No disclosure on file
Arpita Lakhotia, MD, FAAN Dr. Lakhotia has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Lakhotia has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Mahmoud Shaqfeh, MD No disclosure on file
Gupta V. Harsh, MD No disclosure on file
Prateek Thatikunta, MD No disclosure on file
Lars Bergmann, MD Lars Bergmann has received personal compensation for serving as an employee of Abbvie. Lars Bergmann has stock in Abbvie.